Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Molecular Diagnostic Tool for Endometrial Cancer.

NCT06192017 is registered in ClinicalTrials.gov with MiMARK Diagnostics, S.L. as lead sponsor.

NCT NCT06192017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06192017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Molecular Diagnostic Tool for Endometrial Cancer.
Lead sponsor
MiMARK Diagnostics, S.L.
Phase
Observational
Overall status
Completed
Start date
October 18, 2023
Completion date
July 31, 2025
Enrollment
1,950 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

endometrium cancer